Published in Colorectal Dis on April 29, 2010
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer. PLoS One (2012) 0.84
A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity. Cancer Prev Res (Phila) (2012) 0.84
Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis. J Carcinog (2012) 0.75
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet (1987) 4.32
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci (1995) 2.75
Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology (1983) 2.23
Helicobacter pylori: the cancer link. J R Soc Med (1996) 2.15
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther (2015) 2.00
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Elemental diets in treatment of acute Crohn's disease. Br Med J (1980) 1.92
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Duodeno-jejunal adenocarcinoma as a first presentation of coeliac disease. J Clin Pathol (1996) 1.70
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment Pharmacol Ther (1991) 1.56
Gallstone clearance: a randomized study of extracorporeal shock wave lithotripsy and chemical dissolution. Br J Surg (1990) 1.54
Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralized facility testing. Eur J Gastroenterol Hepatol (2000) 1.41
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther (2005) 1.34
The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis (2012) 1.28
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Formation of indigo by recombinant mammalian cytochrome P450. Biochem Biophys Res Commun (1999) 1.24
Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol (1992) 1.24
Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther (2011) 1.22
DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res (2007) 1.22
Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut (1996) 1.19
Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut (1984) 1.17
Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos (1998) 1.15
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut (1990) 1.15
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci (1995) 1.14
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer (2004) 1.11
Extension of selection criteria for extracorporeal shock wave lithotripsy for gall stones. BMJ (1989) 1.09
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet (2001) 1.08
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
Replication of restless legs syndrome loci in three European populations. J Med Genet (2009) 1.08
Percutaneous endoscopic gastrostomy--its application in patients with neurological disease. Ir J Med Sci (1993) 1.07
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ (1991) 1.06
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis (2014) 1.04
Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol (2005) 1.03
Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy (2011) 1.02
Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis (2012) 1.00
Atraumatic non-distorting pyloric sphincter pressure studies. Gut (1980) 0.98
Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomarkers Prev (1993) 0.98
Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? Aliment Pharmacol Ther (2009) 0.97
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther (2004) 0.96
Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut (1990) 0.96
Helicobacter pylori eradication--a surrogate marker for duodenal ulcer healing. Eur J Gastroenterol Hepatol (1996) 0.95
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Aliment Pharmacol Ther (1998) 0.95
CARD4/NOD1 is not involved in inflammatory bowel disease. Gut (2003) 0.94
Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther (2007) 0.92
Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol (1996) 0.92
Localization of male-specifically expressed MROS genes of Silene latifolia by PCR on flow-sorted sex chromosomes and autosomes. Genetics (2001) 0.91
Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut (1993) 0.90
Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Mutat Res (2008) 0.90
Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease. J Clin Pathol (1983) 0.90
Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat (2009) 0.89
Relationship between the capacity to repair 8-oxoguanine, biomarkers of genotoxicity and individual susceptibility in styrene-exposed workers. Mutat Res (2007) 0.89
Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy. Am J Gastroenterol (1988) 0.89
Epithelial patchy necrosis in Crohn's disease. Hum Pathol (1983) 0.89
Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol (1997) 0.88
Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther (2008) 0.88
Piezoelectric lithotripsy for gallstones: analysis of results in patients with extended selection. Br J Surg (1991) 0.88
Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma (2010) 0.88
Evaluation of different solid media used for cultivation of Helicobacter (Campylobacter) pylori. Indian J Med Res (1992) 0.88
High prevalence of vitamin D insufficiency in healthy Irish adults. Ir J Med Sci (2008) 0.88
Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res (2001) 0.87
Accumulation of the proteolytic marker peptide ubiquitin in the trophoblast of mammalian blastocysts. Cloning Stem Cells (2001) 0.87
Biomonitoring of genotoxic risk in workers in a rubber factory: comparison of the Comet assay with cytogenetic methods and immunology. Mutat Res (1999) 0.87
An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat Res (1999) 0.86
Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease. Scand J Gastroenterol (1985) 0.86
Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics (2000) 0.86
Prevalence of Helicobacter pylori in non-ulcer dyspepsia. Aliment Pharmacol Ther (1995) 0.86
Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer. Aliment Pharmacol Ther (1993) 0.86
Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Carcinogenesis (2010) 0.85